Preventive Effect of Angiotensin II Receptor Blockers on High-Dose Methotrexate-Induced Hepatotoxicity Determined Using a Hospital-Based Database Analysis
Biological and Pharmaceutical Bulletin · 05.11.2026 · 49 (11) · 1846-1852
DOI: 10.1248/bpb.b25-00724 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, erschienen am 05.11.2026. Verfasst von Ayu Miyata und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo 105-8512, Japan. Hauptthemen laut MEDLINE: Methotrexate, Chemical and Drug Induced Liver Injury, Angiotensin Receptor Antagonists, Antimetabolites, Antineoplastic. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo 105-8512, Japan.
Zitieren
APA
Miyata, A., Imai, S., Tsuchiya, M., Kizaki, H., & Hori, S. (2026). Preventive Effect of Angiotensin II Receptor Blockers on High-Dose Methotrexate-Induced Hepatotoxicity Determined Using a Hospital-Based Database Analysis. Biological and Pharmaceutical Bulletin, 49(11), 1846-1852. https://doi.org/10.1248/bpb.b25-00724
Vancouver
Miyata A, Imai S, Tsuchiya M, Kizaki H, Hori S. Preventive Effect of Angiotensin II Receptor Blockers on High-Dose Methotrexate-Induced Hepatotoxicity Determined Using a Hospital-Based Database Analysis. Biological and Pharmaceutical Bulletin. 2026;49(11):1846-1852. doi:10.1248/bpb.b25-00724
BibTeX
@article{Miyata2026,
author = {Miyata, Ayu and Imai, Shungo and Tsuchiya, Masami and Kizaki, Hayato and Hori, Satoko},
title = {Preventive Effect of Angiotensin II Receptor Blockers on High-Dose Methotrexate-Induced Hepatotoxicity Determined Using a Hospital-Based Database Analysis},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
volume = {49},
number = {11},
pages = {1846--1852},
doi = {10.1248/bpb.b25-00724}
}
EUVIMED